Biomaterials for Research and Industry

© Fraunhofer ISC
Therapeutic wound patch

The TLC-RT develops synthetic as well as bio-logically based materials, e. g. (μ- and nano-) particles, fibers, coatings for regenerative medicine, tissue engineering and diagnostics. One of the core tasks is to cover the entire value chain, starting from R&D-tasks over process up-scaling, pre-clinic evaluation to the clinical phases.

The TLC-RT provides both the infrastructure for and the experience in processing and manufacturing biomaterials on a pilot scale. Expertise in implementing automated processes for the material synthesis under GMP-compliant conditions and down-stream services as material testing of biocompatibility according to DIN EN ISO 10993 standards and – more advanced – in complex human 3D in-vitro tissue models, which bear a higher predictive power compared to animal tests, completes the supply.

Current activities are focused on biohybrid and biodegradable materials with biofunctionalization, biologized surfaces or controlled drug release properties.

Regenerative
Biomaterials

In vitro and in vivo
diagnostics

Drug delivery

Future technologies

Your contact person on site

Sofia Dembski

Contact Press / Media

Dr. Sofia Dembski

Head of Biomaterials

Fraunhofer Translational Center Regenerative Therapies TLC-RT
Neunerplatz 2
97082 Würzburg, Germany

Phone +49 931 4100-516

Fax +49 931 4100-399

Jörn Probst

Contact Press / Media

Dr. Jörn Probst

Head of Biomaterials and Strategy Development

Translational Center Regenerative Therapies TLC-RT
Neunerplatz 2
97082 Würzburg, Germany

Phone +49 931 4100-300